Literature DB >> 28347649

The effect of intraarticular serum rich in growth factors (SRGF) on knee osteoarthritis in the rat model.

Shahrzad Azizi1, Reza Kheirandish2, Alireza Farsinejad3, Najmeh Rasouli4.   

Abstract

Osteoarthritis (OA) is a degenerative joint disease with high incidence in world. Various treatments have been used for decreasing pain and improving physical function without clearly beneficial evidences. Nowadays, platelet-rich therapy is used as a novel approach in field of regenerative medicine. The present study evaluated the effect of intraarticular serum rich in growth factors (SRGF) on the monosodium iodoacetate induced-osteoarthritis in rat model. SRGF was injected 3 times weekly. Femorotibial joints were examined 2 weeks after last injection. Histopathologic results showed remarkable articular regeneration in the SRGF treated rats. Our findings were less surface irregularities and articular clefts, proliferation of chondrocytes and increasing synthesis of matrix proteoglycan with toluidine blue staining. Destroyed articular cartilage was repaired by fibro-hyaline cartilage in contrast to the OA rats that filled with fibrovascular tissues. The microscopic score had decreased in the treatment group. We concluded that SRGF, as a source of growth factors, have chondroinductive capacity with regard to enhancement of cartilage regeneration.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Histopathology; Osteoarthritis; Platelets; Rat; SRGF

Mesh:

Substances:

Year:  2017        PMID: 28347649     DOI: 10.1016/j.transci.2017.02.006

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  1 in total

Review 1.  Platelet-rich plasma injections induce disease-modifying effects in the treatment of osteoarthritis in animal models.

Authors:  Angelo Boffa; Manuela Salerno; Giulia Merli; Laura De Girolamo; Lior Laver; Jérémy Magalon; Mikel Sánchez; Thomas Tischer; Giuseppe Filardo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-08-02       Impact factor: 4.342

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.